FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

377565009: Prednisolone acetate + sulfacetamide sodium 0.25%wv/10%wv suspension (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1202884012 Prednisolone acetate + sulfacetamide sodium 0.25%wv/10%wv suspension (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1478906011 Prednisolone acetate+sulfacetamide sodium 0.25%wv/10%wv suspension en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2871170016 Prednisolone acetate + sulphacetamide sodium 0.25%wv/10%wv suspension en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3832501000005117 prednisolonacetat + sulfacetamidnatrium 0,25 % wt/vol/10 % wt/vol suspension da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    prednisolonacetat + sulfacetamidnatrium 0,25 % wt/vol/10 % wt/vol suspension Is a Product containing sulfacetamide (medicinal product) false Inferred relationship Some
    prednisolonacetat + sulfacetamidnatrium 0,25 % wt/vol/10 % wt/vol suspension Is a Product containing prednisolone (medicinal product) false Inferred relationship Some
    prednisolonacetat + sulfacetamidnatrium 0,25 % wt/vol/10 % wt/vol suspension Is a Product containing prednisolone in ocular dose form (medicinal product form) false Inferred relationship Some
    prednisolonacetat + sulfacetamidnatrium 0,25 % wt/vol/10 % wt/vol suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Sulfacetamide (substance) false Inferred relationship Some
    prednisolonacetat + sulfacetamidnatrium 0,25 % wt/vol/10 % wt/vol suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Prednisolone ophthalmic preparation false Inferred relationship Some
    prednisolonacetat + sulfacetamidnatrium 0,25 % wt/vol/10 % wt/vol suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Prednisolone acetate false Inferred relationship Some
    prednisolonacetat + sulfacetamidnatrium 0,25 % wt/vol/10 % wt/vol suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Corticosterone false Inferred relationship Some
    prednisolonacetat + sulfacetamidnatrium 0,25 % wt/vol/10 % wt/vol suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Sulfacetamide sodium false Inferred relationship Some
    prednisolonacetat + sulfacetamidnatrium 0,25 % wt/vol/10 % wt/vol suspension Is a prednisolonacetat + sulfacetamidnatrium false Inferred relationship Some
    prednisolonacetat + sulfacetamidnatrium 0,25 % wt/vol/10 % wt/vol suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. binyrehormonmiddel false Inferred relationship Some
    prednisolonacetat + sulfacetamidnatrium 0,25 % wt/vol/10 % wt/vol suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. glucocorticoidhormon false Inferred relationship Some
    prednisolonacetat + sulfacetamidnatrium 0,25 % wt/vol/10 % wt/vol suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Baktericid false Inferred relationship Some
    prednisolonacetat + sulfacetamidnatrium 0,25 % wt/vol/10 % wt/vol suspension Has manufactured dose form Ocular dose form (dose form) false Inferred relationship Some
    prednisolonacetat + sulfacetamidnatrium 0,25 % wt/vol/10 % wt/vol suspension Has manufactured dose form lægemiddelsuspension false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Description inactivation indicator reference set

    Back to Start